BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15842589)

  • 1. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
    Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
    Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion of the bacterial sensor NOD2 improves murine Crohn's disease-like ileitis independent of functional dysbiosis.
    Corridoni D; Rodriguez-Palacios A; Di Stefano G; Di Martino L; Antonopoulos DA; Chang EB; Arseneau KO; Pizarro TT; Cominelli F
    Mucosal Immunol; 2017 Jul; 10(4):971-982. PubMed ID: 27848951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polymorphisms in the TNFA, TNFRSF1A and TNFRSF1B genes with lepromatous leprosy in Western Mexican patients.
    Montoya-Buelna M; Alvarado-Navarro A; Muñoz-Valle JF; Lopez-Roa RI; Guerrero-Velazquez C; Fafutis-Morris M
    J Infect Dev Ctries; 2024 May; 18(5):770-778. PubMed ID: 38865403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's Disease.
    Moret-Tatay I; Cerrillo E; Sáez-González E; Hervás D; Iborra M; Sandoval J; Busó E; Tortosa L; Nos P; Beltrán B
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00083. PubMed ID: 31663908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
    Gregory AP; Dendrou CA; Attfield KE; Haghikia A; Xifara DK; Butter F; Poschmann G; Kaur G; Lambert L; Leach OA; Prömel S; Punwani D; Felce JH; Davis SJ; Gold R; Nielsen FC; Siegel RM; Mann M; Bell JI; McVean G; Fugger L
    Nature; 2012 Aug; 488(7412):508-511. PubMed ID: 22801493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the ILR1 and FAS gene variants with primary nonresponse to anti-tumor necrosis factor therapy in patients with Crohn disease.
    Lykowska-Szuber L; Skrzypczak-Zielinska M; Zuraszek J; Walczak M; Stawczyk-Eder K; Krela-Kazmierczak I; Michalak M; Slomski R; Dobrowolska A
    Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 36916302
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Carvalho BF; Gomez GVB; Carron J; Macedo LT; Gonçalves GM; Vazquez VL; Serrano SV; Lourenço GJ; Lima CSP
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular reclassification of Crohn's disease: a cautionary note on population stratification.
    Maus B; Jung C; Mahachie John JM; Hugot JP; Génin E; Van Steen K
    PLoS One; 2013; 8(10):e77720. PubMed ID: 24147066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in
    Naser A; Odeh AK; Sharp RC; Qasem A; Beg S; Naser SA
    Microorganisms; 2019 Dec; 7(12):. PubMed ID: 31817071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic Analysis of the
    Nani P; Ladopoulou M; Papaioannou EH; Papagianni ED; Antonatos C; Xiropotamos P; Kapsoritakis A; Potamianos PS; Karmiris K; Tzathas C; Patsatsi A; Lazaridou E; Zafiriou E; Roussaki-Schulze A; Georgiou S; Grafanaki K; Georgakilas GK; Vasilopoulos Y
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis.
    Sudhakar P; Verstockt B; Cremer J; Verstockt S; Sabino J; Ferrante M; Vermeire S
    Inflamm Bowel Dis; 2021 May; 27(6):870-886. PubMed ID: 33313682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease.
    Cleynen I; Konings P; Robberecht C; Laukens D; Amininejad L; Théâtre E; Machiels K; Arijs I; Rutgeerts P; Louis E; Franchimont D; De Vos M; Van Steen K; Georges M; Moreau Y; Vermeesch J; Vermeire S
    Inflamm Bowel Dis; 2016 Mar; 22(3):505-15. PubMed ID: 26595553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study of 71 European Crohn's disease susceptibility loci in a Japanese population.
    Hirano A; Yamazaki K; Umeno J; Ashikawa K; Aoki M; Matsumoto T; Nakamura S; Ninomiya T; Matsui T; Hirai F; Kawaguchi T; Takazoe M; Tanaka H; Motoya S; Kiyohara Y; Kitazono T; Nakamura Y; Kamatani N; Kubo M
    Inflamm Bowel Dis; 2013 Mar; 19(3):526-33. PubMed ID: 23388546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease.
    Momozawa Y; Mni M; Nakamura K; Coppieters W; Almer S; Amininejad L; Cleynen I; Colombel JF; de Rijk P; Dewit O; Finkel Y; Gassull MA; Goossens D; Laukens D; Lémann M; Libioulle C; O'Morain C; Reenaers C; Rutgeerts P; Tysk C; Zelenika D; Lathrop M; Del-Favero J; Hugot JP; de Vos M; Franchimont D; Vermeire S; Louis E; Georges M
    Nat Genet; 2011 Jan; 43(1):43-7. PubMed ID: 21151126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population.
    Ferguson LR; Han DY; Fraser AG; Huebner C; Lam WJ; Morgan AR; Duan H; Karunasinghe N
    Mutat Res; 2010 Aug; 690(1-2):108-15. PubMed ID: 20109474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans.
    Yang SK; Park M; Lim J; Park SH; Ye BD; Lee I; Song K
    Inflamm Bowel Dis; 2009 Sep; 15(9):1385-90. PubMed ID: 19334001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease.
    Yamazaki K; McGovern D; Ragoussis J; Paolucci M; Butler H; Jewell D; Cardon L; Takazoe M; Tanaka T; Ichimori T; Saito S; Sekine A; Iida A; Takahashi A; Tsunoda T; Lathrop M; Nakamura Y
    Hum Mol Genet; 2005 Nov; 14(22):3499-506. PubMed ID: 16221758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking.
    Liu L; Wu Y; Ye K; Cai M; Zhuang G; Wang J
    Front Pharmacol; 2022; 13():924197. PubMed ID: 35865955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis.
    Khan IA; Nayak B; Markandey M; Bajaj A; Verma M; Kumar S; Singh MK; Kedia S; Ahuja V
    PLoS One; 2021; 16(8):e0256098. PubMed ID: 34407136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF Receptor 1 Promotes Early-Life Immunity and Protects against Colitis in Mice.
    Liu CY; Tam SS; Huang Y; Dubé PE; Alhosh R; Girish N; Punit S; Nataneli S; Li F; Bender JM; Washington MK; Polk DB
    Cell Rep; 2020 Oct; 33(3):108275. PubMed ID: 33086075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.